Amendment No. 2 to Collaboration and License AgreementCollaboration and License Agreement • March 28th, 2008 • Memory Pharmaceuticals Corp • Pharmaceutical preparations • New York
This Amendment No. 2 to Collaboration and License Agreement (“Amendment”) is made effective as of February 8, 2008 (“Amendment Date”) by and between Memory Pharmaceuticals Corp., a Delaware corporation (“Memory”) and Amgen Inc., a Delaware corporation (“Amgen”).
Memory Pharmaceuticals Corp. 100 Philips Parkway Montvale, New Jersey 07645 Phone: (201) 802-7100 Fax: (201) 802-7190 www.memorypharma.com February 19, 2008 Mr. Vaughn M. Kailian [address] Dear Vaughn:Interim Employment Agreement • March 28th, 2008 • Memory Pharmaceuticals Corp • Pharmaceutical preparations • New Jersey
The following sets forth our agreement relating to your serving on an interim basis as the Interim President and Chief Executive Officer of Memory Pharmaceuticals Corp. (the “Company”).
